CHITOGEN™
MEDIFAB's proprietary ingredient made by solubilizing insoluble chitosan and applying LTG (Liquid-to-Gel) technology to preserve anti-inflammatory, antioxidant, and skin-recovery properties.
MEDIFAB Co., Ltd. is a global medical aesthetics and anti-aging company that sets the standard for the future of regenerative medicine.
Chitogen™ is MEDIFAB's proprietary ingredient made by solubilizing insoluble chitosan and applying LTG (Liquid-to-Gel) technology to preserve anti-inflammatory, antioxidant, and skin-recovery properties.
Regentrix™ is a regenerative signaling platform developed as a dECM (Decellularized Extracellular Matrix) material by decellularizing xenogeneic dermal tissue through a supercritical CO₂ process.
Chitosan-based molecular engineering powers three distinct technology platforms — each validated through clinical evidence and global regulatory approval.
View All R&DMEDIFAB's proprietary ingredient made by solubilizing insoluble chitosan and applying LTG (Liquid-to-Gel) technology to preserve anti-inflammatory, antioxidant, and skin-recovery properties.
A regenerative signaling platform developed as a dECM (Decellularized Extracellular Matrix) material by decellularizing xenogeneic dermal tissue through a supercritical CO₂ process.
A hybrid biomaterial that combines Chitogen™ — water-solubilized chitosan processed with LTG — and Regentrix™, a dECM-based platform. Designed so cells can recover on their own by shaping both conditions and signals together.
MEDIFAB provides comprehensive anti-aging solutions spanning professional medical aesthetics to everyday home care.
Skin boosters developed on MEDIFAB's proprietary technology platforms — Chitogen™, Regentrix™, and Chitogenix™. By combining the biocompatibility of chitosan-derived materials with tissue regeneration technology, they work with the skin's own capacity to recover.
A lineup of medical devices including bioresorbable implants and HA fillers. Built on materials engineered to break down safely within the body, they support clinical environments that account for the full course of recovery.
res novae is a high-performance dermocosmetic brand spanning both skin and scalp care. It extends MEDIFAB's research into everyday routines, helping restore balance to sensitized skin barriers and scalp conditions.
MEDINOVAE is a clinical brand built on cell-boosting technology. Its formulations focus on activity at the cellular level, designed to integrate reliably into professional treatment protocols.
Strengthening customer touchpoints through pharmacy-style flagship stores and introducing beauty device and scalp care lineups. [Economist Reporter Lee Hyun-ah] Beauty brands are currently working to expand offline stores to strengthen skinship (engagement) with domestic and international customers. By diversifying distribution through various platforms such as Olive Young and Daiso, as well as pharmacy-style flagship stores...
See ArticleGlobal medical aesthetics company MEDIFAB successfully concluded its participation in ‘AMWC Korea 2026’, held at the InterContinental Seoul Parnas from June 19 to 20. Hwang Seung-guk, Chairman of KOAT (Korean Academy of Obesity and Aesthetics), who planned the inaugural AMWC Korea, and Cha Mi-sun, CEO of MEDIFAB, who won the Best Innovation Award for its LTG technology. This conference is a world-class…
See ArticleMedical aesthetic specialized company MEDIFAB announced that it participated in the Central Asia Beauty Expo 2026 held at the Atakent Expo Center in Almaty, Kazakhstan, on May 28, establishing a bridgehead for entry into the CIS and Central Asian markets. At this exhibition, MEDIFAB met with buyers from Kazakhstan, Uzbekistan, Kyrgyzstan, and the Middle East...
See ArticleLeave your inquiry about distribution partnerships, product import/export, or ODM collaboration.